UK's AstraZeneca begins human trial of Covid-19 treatment using monoclonal antibodies

UK-based pharmaceutical company AstraZeneca announced on Tuesday that it had begun the human trial of a new treatment for Covid-19 using a combination of two monoclonal antibodies.

from UK News Headlines, Latest UK News and Live Updates - Times of India https://ift.tt/2QqNUQY